Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-25
1996-07-09
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548152, 548178, 548179, A61K 31425, C07D27764, C07D27766
Patent
active
055345328
ABSTRACT:
This invention relates to a class of novel aliphatic amino bis-aryl compounds containing at least four carbon atoms and an amino group either substituted thereon or incorporated therein and is further linked or bridged to two mono- and/or bicyclic rings. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.
REFERENCES:
Fujita et al., Chem. Pharm. Bull., 38(4), 936-941 (1990).
Groneberg Robert A.
Neuenschwander Kent W.
Regan John R.
Scotese Anthony C.
Cross Laura R.
Nicholson James A.
Parker III Raymond S.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Richter Johann
LandOfFree
Aliphatic amino bis-aryl squalene synthase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aliphatic amino bis-aryl squalene synthase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aliphatic amino bis-aryl squalene synthase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1867520